Abatacept biosimilar (Momenta Pharmaceuticals)

阿巴西普生物类似药 (Momenta Pharmaceuticals)

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAbatacept biosimilar (Momenta Pharmaceuticals)
Drug Alias Name阿巴西普生物仿制药 (Momenta Pharmaceuticals)CTLA4-Ig Fusion protein (Momenta Pharmaceuticals)Recombinant human CTLA4-Ig Fusion protein (Momenta Pharmaceuticals)M-834
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionCluster of differentiation 80 modulatorsCluster of differentiation 86 modulators
TargetsCluster of differentiation 80Cluster of differentiation 86
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMomenta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMylan IncMomenta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeL04AA24
Related LinksN/A